Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety, tolerability and pharmacokinetics of multiple
oral 200-mg doses of PF-05175157 administered twice daily for 14 days in healthy overweight
and obese subjects.